With grey areas aplenty, India's marketing code in autopilot?
This article was originally published in Scrip
Ambiguities in India's new Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) appear to have stretched early compliance deadlines via autopilot mode.
You may also be interested in...
India's uniform code for pharmaceuticals marketing practices, so far voluntary in nature, appears to be on course to becoming "statutory" and "mandatory", signaling some potential short-term turbulence in the growing domestic market.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
Dr Reddy’s combines forces with the Russian Direct Investment Fund for clinical trials and supply of Sputnik V in India, amid what it views as “very important” data points in early studies of the COVID-19 vaccine.